DODB

DODB
Clinical data
Other names6-Bromo-DOB; 2,5-Dimethoxy-4,6-dibromoamphetamine; 2,4-Dibromo-3,6-dimethoxyamphetamine
Routes of
administration		Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action12–20 hours[1]
Identifiers
  • 1-(2,4-dibromo-3,6-dimethoxyphenyl)propan-2-amine
Chemical and physical data
FormulaC11H15Br2NO2
Molar mass353.054 g·mol−1
3D model (JSmol)
  • COc1c(Br)cc(c(c1Br)CC(N)C)OC
  • InChI=1S/C11H15Br2NO2/c1-6(14)4-7-9(15-2)5-8(12)11(16-3)10(7)13/h5-6H,4,14H2,1-3H3
  • Key:MFEJTCMFVXAELO-UHFFFAOYSA-N

DODB, also known as 2,5-dimethoxy-4,6-dibromoamphetamine or as 6-bromo-DOB, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families related to DOB.[1] It is the 6-bromo derivative of DOB and the 4,6-dibromo derivative of 2,5-dimethoxyamphetamine (2,5-DMA; DOH).[1] The drug has a dose range of 5 to 8 mg orally and a duration of 12 to 20 hours.[1] For comparison, DOB has a dose of 1 to 3 mg and a duration of 18 to 30 hours.[1] DODB is described as having largely the same effects as DOB.[1] However, it is said that the drug may have somewhat greater visual effects than DOB and that its physical side effects appear to be less pronounced than those of DOB.[1] DODB was synthesized and tested by P. Rausch in the 1990s or 2000s.[1][2] It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source for the information.[1] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[3]

See also

References

  1. ^ a b c d e f g h i j Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. p. 921. ISBN 978-3-03788-700-4. OCLC 858805226. Archived from the original on 21 August 2025.
  2. ^ Rausch P (January 1995). Leuner H, Schlichting M (eds.). Jahrbuch des Europäischen Collegiums für Bewußtseinsstudien: 1995 [Yearbook of the European College for the Study of Consciousness: 1995] (in German and English). Vol. 4. Berlin: VWB. ISBN 3861354071. ISSN 0942-7600. OCLC 28636362.
  3. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.